276 related articles for article (PubMed ID: 22178893)
1. Antiangiogenic and radiation therapy: early effects on in vivo computed tomography perfusion parameters in human colon cancer xenografts in mice.
Ren Y; Fleischmann D; Foygel K; Molvin L; Lutz AM; Koong AC; Jeffrey RB; Tian L; Willmann JK
Invest Radiol; 2012 Jan; 47(1):25-32. PubMed ID: 22178893
[TBL] [Abstract][Full Text] [Related]
2. CT perfusion as an imaging biomarker in monitoring response to neoadjuvant bevacizumab and radiation in soft-tissue sarcomas: comparison with tumor morphology, circulating and tumor biomarkers, and gene expression.
Kambadakone A; Yoon SS; Kim TM; Karl DL; Duda DG; DeLaney TF; Sahani DV
AJR Am J Roentgenol; 2015 Jan; 204(1):W11-8. PubMed ID: 25539263
[TBL] [Abstract][Full Text] [Related]
3. Dynamic contrast-enhanced micro-computed tomography correlates with 3-dimensional fluorescence ultramicroscopy in antiangiogenic therapy of breast cancer xenografts.
Pöschinger T; Renner A; Eisa F; Dobosz M; Strobel S; Weber TG; Brauweiler R; Kalender WA; Scheuer W
Invest Radiol; 2014 Jul; 49(7):445-56. PubMed ID: 24598441
[TBL] [Abstract][Full Text] [Related]
4. Fractal analysis of CT perfusion images for evaluation of antiangiogenic treatment and survival in hepatocellular carcinoma.
Hayano K; Lee SH; Yoshida H; Zhu AX; Sahani DV
Acad Radiol; 2014 May; 21(5):654-60. PubMed ID: 24703479
[TBL] [Abstract][Full Text] [Related]
5. Effect of scan time on perfusion and flow extraction product (K-trans) measurements in lung cancer using low-dose volume perfusion CT (VPCT).
Spira D; Gerlach JD; Spira SM; Schulze M; Sauter A; Horger M
Acad Radiol; 2012 Jan; 19(1):78-83. PubMed ID: 22054806
[TBL] [Abstract][Full Text] [Related]
6. CT perfusion of renal cell carcinoma: impact of volume coverage on quantitative analysis.
Reiner CS; Goetti R; Eberli D; Klotz E; Boss A; Pfammatter T; Frauenfelder T; Moch H; Sulser T; Alkadhi H
Invest Radiol; 2012 Jan; 47(1):33-40. PubMed ID: 21730874
[TBL] [Abstract][Full Text] [Related]
7. Three-dimensional Dynamic Contrast-enhanced US Imaging for Early Antiangiogenic Treatment Assessment in a Mouse Colon Cancer Model.
Wang H; Hristov D; Qin J; Tian L; Willmann JK
Radiology; 2015 Nov; 277(2):424-34. PubMed ID: 26020439
[TBL] [Abstract][Full Text] [Related]
8. Improving quantitative CT perfusion parameter measurements using principal component analysis.
Yeung TP; Dekaban M; De Haan N; Morrison L; Hoffman L; Bureau Y; Chen X; Yartsev S; Bauman G; Lee TY
Acad Radiol; 2014 May; 21(5):624-32. PubMed ID: 24703475
[TBL] [Abstract][Full Text] [Related]
9. [Feasibility of volume perfusion CT (VPCT) imaging in antiangiogenic treatment of rabbit VX2 soft-tissue tumor].
Yang P; Feng XW; Ye ZX; Li XB; Hou Y; Liu YT; Xiao JY
Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):341-6. PubMed ID: 24054009
[TBL] [Abstract][Full Text] [Related]
10. Assessment of acute antivascular effects of vandetanib with high-resolution dynamic contrast-enhanced computed tomographic imaging in a human colon tumor xenograft model in the nude rat.
Tai JH; Tessier J; Ryan AJ; Hoffman L; Chen X; Lee TY
Neoplasia; 2010 Sep; 12(9):697-707. PubMed ID: 20824046
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of one-stop CT energy spectrum and perfusion for angiogenesis in colon and rectum cancer.
Zhao L; Zhou W; Fu Y; Ge Y; Feng L; Wang X; Li Z; Chen W
BMC Med Imaging; 2024 May; 24(1):116. PubMed ID: 38773384
[TBL] [Abstract][Full Text] [Related]
12. Whole-tumour CT-perfusion of unresectable lung cancer for the monitoring of anti-angiogenetic chemotherapy effects.
Fraioli F; Anzidei M; Serra G; Liberali S; Fiorelli A; Zaccagna F; Longo F; Anile M; Catalano C
Br J Radiol; 2013 Sep; 86(1029):20120174. PubMed ID: 23908346
[TBL] [Abstract][Full Text] [Related]
13. Multiparametric monitoring of early response to antiangiogenic therapy: a sequential perfusion CT and PET/CT study in a rabbit VX2 tumor model.
Kim JI; Lee HJ; Kim YJ; Kim KG; Lee KW; Lee JH; Lee HJ; Lee WW
ScientificWorldJournal; 2014; 2014():701954. PubMed ID: 25383376
[TBL] [Abstract][Full Text] [Related]
14. Role of CT perfusion imaging in patients with variously differentiated gastric adenocarcinoma.
Sun ZQ; Cheng XF; Ge YX; Chen L; Yue JG; Jin LF; Xie ZH; Zhang HD; Xuan YH
J Xray Sci Technol; 2015; 23(6):737-44. PubMed ID: 26756409
[TBL] [Abstract][Full Text] [Related]
15. Monitoring response to antiangiogenic treatment and predicting outcomes in advanced hepatocellular carcinoma using image biomarkers, CT perfusion, tumor density, and tumor size (RECIST).
Jiang T; Kambadakone A; Kulkarni NM; Zhu AX; Sahani DV
Invest Radiol; 2012 Jan; 47(1):11-7. PubMed ID: 21512396
[TBL] [Abstract][Full Text] [Related]
16. Quantification of variability in breath-hold perfusion CT of hepatocellular carcinoma: a step toward clinical use.
Petralia G; Summers P; Viotti S; Montefrancesco R; Raimondi S; Bellomi M
Radiology; 2012 Nov; 265(2):448-56. PubMed ID: 22996748
[TBL] [Abstract][Full Text] [Related]
17. Dynamic Contrast-Enhanced Computed Tomography-Derived Blood Volume and Blood Flow Correlate With Patient Outcome in Metastatic Renal Cell Carcinoma.
Mains JR; Donskov F; Pedersen EM; Madsen HH; Rasmussen F
Invest Radiol; 2017 Feb; 52(2):103-110. PubMed ID: 27513367
[TBL] [Abstract][Full Text] [Related]
18. Liver metastases from colorectal cancer treated with conventional and antiangiogenetic chemotherapy: evaluation with liver computed tomography perfusion and magnetic resonance diffusion-weighted imaging.
Anzidei M; Napoli A; Zaccagna F; Cartocci G; Saba L; Menichini G; Cavallo Marincola B; Marotta E; Di Mare L; Catalano C; Passariello R
J Comput Assist Tomogr; 2011; 35(6):690-6. PubMed ID: 22082538
[TBL] [Abstract][Full Text] [Related]
19. Perfusion CT assessment of tissue hemodynamics following hepatic arterial infusion of increasing doses of angiotensin II in a rabbit liver tumor model.
Wright KC; Ravoori MK; Dixon KA; Han L; Singh SP; Liu P; Gupta S; Johnson VE; Kan Z; Kundra V
Radiology; 2011 Sep; 260(3):718-26. PubMed ID: 21633050
[TBL] [Abstract][Full Text] [Related]
20. Early antiangiogenic activity of bevacizumab evaluated by computed tomography perfusion scan in patients with advanced hepatocellular carcinoma.
Zhu AX; Holalkere NS; Muzikansky A; Horgan K; Sahani DV
Oncologist; 2008 Feb; 13(2):120-5. PubMed ID: 18305056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
